Skip to content

Clinical trials

Thyroid Cancer, Papillary trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Thyroid Cancer, Papillary Country / region: Australia Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20121
20151
20171
20181
20191
20212
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting4
Terminated2
Approved for marketing1
Completed1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company3
Aminex Therapeutics, Inc.1
Children's Hospital of Philadelphia1
Day One Biopharmaceuticals, Inc.1
Exelixis1
Hoffmann-La Roche1
National Cancer Institute (NCI)1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Thyroid Cancer, Papillary9
Carcinoma, Non-Small-Cell Lung6
Breast Neoplasms5
Head and Neck Neoplasms4
Neoplasms4
Thyroid Neoplasms4
Carcinoma, Medullary3
Colonic Neoplasms3
Colorectal Neoplasms3
Melanoma3

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.